Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer Institute
1 Views
administrator
07/01/23
Dana-Farber research into autologous stem cell transplant for patients with multiple myeloma: study led by Dr. Paul G. Richardson, MD, found patients had dramatically increased progression-free survival, but were just as likely to be alive more than 6 years later if they chose to reserve their transplant until later. Press release: https://bit.ly/3cgaZ7l Video published: 7/14/22
-
Category
Show more
Facebook Comments
No comments found